Еmergencies in valvular heart disease in the practice of therapists, general practitioners and clinical physiologists

• Igor N. Posokhov

Abstract

This review is intended for therapists, general practitioners, clinical physiologists and it’s aim is to develop competencies that allow specialists to recognize and take first steps to stabilize patients with emergencies in valvular heart disease, as well as have an idea of the options for further care until final recovery. The main hemodynamic and clinical manifestations of these conditions are given, including signs in echocardiography, as well as applied or contraindicated medical therapy and temporary mechanical circulatory support; the possibilities of definitive repair are mentioned.

Keywords: valvular heart disease; emergencies; decompensation; cardiogenic shock

References

1. Bohula E.A., Katz J.N., van Diepen S., et al. Demographics, care patterns, and outcomes of patients admitted to cardiac intensive care units: the critical care cardiology trials network prospective North American Multicenter Registry of Cardiac Critical Illness. JAMA Cardiol. 2019; 4 (9): 928–35. DOI: https://doi.org/10.1001/jamacardio.2019.2467
2. Association of Cardiovascular Surgeons of Russia. Clinical Guidelines. URL: https://racvs.ru/clinic/ (date of access October 24, 2024). (in Russian)
3. 2020 Clinical practice guidelines for Chronic heart failure. Rossiyskiy kardiologicheskiy zhurnal [Russian Journal of Cardiology]. 2020; 25 (11): 311–73. DOI: https://doi.org/10.15829/1560-4071-2020-4083 (in Russian)
4. McDonagh T., Metra M. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Rossiyskiy kardiologicheskiy zhurnal [Russian Journal of Cardiology]. 2023; 28 (1): 117–224. DOI: https://doi.org/10.15829/1560-4071-2023-5168 (in Russian)
5. Bugaenko D.V., Fominykh M.V., Eremenko A.A. Current percutaneous left ventricular assist devices. Kardiologiya i serdechno-sosudistaya khirurgiya [Cardiology and Cardiovascular Surgery]. 2018; 11 (3): 35–40. DOI: https://doi.org/10.17116/kardio201811335 (in Russian)
6. Novosadov M.M., Novosadov V.M., Dzhioeva O.N., Drapkina O.M. Practical aspects of managing patients with cardiogenic shock. Rossiyskiy kardiologicheskiy zhurnal [Russian Journal of Cardiology]. 2023; 28 (1S): 100–9. DOI: https://doi.org/10.15829/1560-4071-2023-5337 (in Russian)
7. Keane R.R., Menon V., Cremer P.C. Acute heart valve emergencies. Cardiol Clin. 2024; 42 (2): 237–52. DOI: https://doi.org/10.1016/j.ccl.2024.02.009
8. Posokhov I.N., Moroz-Vadalazhskaya N.N. Oscillometric method: what is it and is it suitable for measuring blood pressure in all patients? Kardiovaskulyarnaya terapiya i profilaktika [Cardiovascular Therapy and Prevention]. 2024; 23 (9): 131–42. DOI: https://doi.org/10.15829/1728-8800-2024-4075 (in Russian)
9. Baumgartner H., Hung J., Bermejo J., et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017; 30 (4): 372–92. DOI: https://doi.org/10.1016/j.echo.2017.02.009
10. Zoghbi W.A., Jone P.N., Chamsi-Pasha M.A., et al. Guidelines for the evaluation of prosthetic valve function with cardiovascular imaging: a report from the American Society of Echocardiography. Developed in collaboration with the Society for Cardiovascular Magnetic Resonance and the Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2024; 37 (1): 2–63. DOI: https://doi.org/10.1016/j.echo.2023.10.004
11. Basile C., Fucile I., Lembo M., et al. Arterial hypertension in aortic valve stenosis: a critical update. J Clin Med. 2021; 10 (23): 5553. DOI: https://doi.org/10.3390/jcm10235553
12. Santana J.M., Dalia A.A., Newton M., et al. Mechanical circulatory support options in patients with aortic valve pathology. J Cardiothorac Vasc Anesth. 2022; 36 (8 pt B): 3318–26. DOI: https://doi.org/10.1053/j.jvca.2022.04.010
13. Ganyukov V.I., Tarasov R.S., Kolesnikov A. Yu., Ganyukov I.V. Transcatheter aortic valve replacement: from idea to implementation. Kompleksnye problemy serdechno-sosudistykh zabolevaniy [Complex Problems of Cardiovascular Diseases]. 2024; 13 (1): 152–64. DOI: https://doi.org/10.17802/2306-1278-2024-13-1-152-164 (in Russian)
14. Otto C.M., Nishimura R.A., Bonow R.O., et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021; 143 (5): e35–71. DOI: https://doi.org/10.1161/CIR.0000000000000932
15. Ignatenko G.A., Vatutin N.T., Taradin G.G., Shevelek A.N., Rakitskaya I.V. Aortic regurgitation: epidemiologic, etiologic, and pathophysiologic characteristics. Klinitsist [Clinician]. 2020; 14 (3-4): 57–68. DOI: https://doi.org/10.17650/1818-8338-2020-14-3-4-K639 (in Russian)
16. Zoghbi W.A., Adams D., Bonow R.O., et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography. Developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017; 30 (4): 303–71. DOI: https://doi.org/10.1016/j.echo.2017.01.007
17. Posokhov I.N., Praskurnichiy E.A., Morozova O.I. Evaluation of the function of prosthetic valves in modern clinical practice. Effektivnaya farmakoterapiya [Effective Pharmacotherapy]. 2024; 20 (26): 54–60. DOI: https://doi.org/10.33978/2307-3586-2024-20-26-54-60 (in Russian)
18. Markides R.I.L., Rosendahl U.P., Roussin I. Silent severe aortic regurgitation due to blunt chest trauma: ignore it at your peril – a case report. Eur Heart J Case Rep. 2024; 8 (10): ytae499. DOI: https://doi.org/10.1093/ehjcr/ytae499
19. Sawaya F.J., Deutsch M.A., Seiffert M., et al. Safety and efficacy of transcatheter aortic valve replacement in the treatment of pure aortic regurgitation in native valves and failing surgical bioprostheses: results from an International Registry Study. JACC Cardiovasc Interv. 2017; 10 (10): 1048–56. DOI: https://doi.org/10.1016/j.jcin.2017.03.004
20. Wunderlich N.C., Beigel R., Siegel R.J. Management of mitral stenosis using 2D and 3D echo-Doppler imaging. JACC Cardiovasc Imaging. 2013; 6 (11): 1191–205. DOI: https://doi.org/10.1016/j.jcmg.2013.07.008
21. Chandrashekar P., Ashangari C., Chadderdon S.M. Imaging of the mitral valve. Interv Cardiol Clin. 2024; 13 (2): 141–53. DOI: https://doi.org/10.1016/j.iccl.2023.12.003
22. Bernard S., Deferm S., Bertrand P.B. Acute valvular emergencies. Eur Heart J Acute Cardiovasc Care. 2022; 11 (8): 653–65. DOI: https://doi.org/10.1093/ehjacc/zuac086
23. Weich H., Herbst P., Smit F., Doubell A. Transcatheter heart valve interventions for patients with rheumatic heart disease. Front Cardiovasc Med. 2023; 10: 1234165. DOI: https://doi.org/10.3389/fcvm.2023.1234165
24. Pu Z., Yu T., Liu X., et al. A modified Carpentier classification in transcatheter edge-to-edge repair for mitral regurgitation. Catheter Cardiovasc Interv. 2024; 104 (4): 870–7. DOI: https://doi.org/10.1002/ccd.31158
25. Estévez-Loureiro R., Lorusso R., Taramasso M., et al. Management of severe mitral regurgitation in patients with acute myocardial infarction: JACC Focus Seminar 2/5. J Am Coll Cardiol. 2024; 83 (18): 1799–817. DOI: https://doi.org/10.1016/j.jacc.2023.09.840
26. Toader D.M. Echocardiographic quantification of mitral apparatus morphology and dynamics in patients with dilated cardiomyopathy. J Int Med Res. 2024; 52 (2): 3000605231209830. DOI: https://doi.org/10.1177/03000605231209830
27. Lancellotti P., Pibarot P., Chambers J., et al. Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper. Eur Heart J Cardiovasc Imaging. 2022; 23 (5): e171–232. DOI: https://doi.org/10.1093/ehjci/jeab253
28. Brugger N., Buffle E. A new interesting formula for the correction of 2D PISA EROA in secondary mitral regurgitation derived from computational fluid dynamics (CFD). Int J Cardiovasc Imaging. 2024; 40 (9): 1821–2. DOI: https://doi.org/10.1007/s10554-024-03237-1
29. Nakata J., Saku K., Nishikawa T., et al. Substantial reduction of acute ischemic mitral regurgitation using Impella in AMI complicated with cardiogenic shock. Int Heart J. 2023; 64 (2): 294–8. DOI: https://doi.org/10.1536/ihj.22-572
30. Ekanem E., Gattani R., Bakhshi H., Tehrani B., Batchelor W. Combined venoarterial ECMO and Impella-CP circulatory support for cardiogenic shock due to papillary muscle rupture. JACC Case Rep. 2020; 2 (14): 2169–72. DOI: https://doi.org/10.1016/j.jaccas.2020.08.007
31. Makeev M.I., Saidova M.A., Safiullina A.A., et al. Prediction of cardiovascular events and structural and functional remodeling of the heart in patients with severe mitral regurgitation of various genesis underwent transcatheter mitral valve repair «edge-to-edge». Kardiologiia [Cardiology]. 2024; 64 (9): 3–15. DOI: https://doi.org/10.18087/cardio.2024.9.n2699 (in Russian, English)
32. Beurton A., Ferté T., Mion S., et al. Risk factors of midterm mortality after aortic valve replacement for severe calcified tricuspid aortic valve stenosis: a retrospective analysis of Perioperative Events Assessment in Adult Cardiac surgery (PESSAC) Registry. J Cardiothorac Vasc Anesth. 2021; 35 (12): 3547–56. DOI: https://doi.org/10.1053/j.jvca.2021.08.018
33. Stout K.K., Daniels C.J., Aboulhosn J.A., et al. 2018 AHA/ACC Guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association. Task Force on clinical practice guidelines. J Am Coll Cardiol. 2019; 73 (12): 1494–563. DOI: https://doi.org/10.1016/j.jacc.2018.08.1028
34. Karavas A.N., Olia K., Scantling D., et al. Management of penetrating cardiac injury and tricuspid regurgitation with extracorporeal-membrane oxygenation (ECMO): a case report. J Cardiothorac Surg. 2024; 19 (1): 64. DOI: https://doi.org/10.1186/s13019-024-02557-6
35. Hembree A., Lawlor M., Nemeth S., et al. Effect of venoarterial extracorporeal membrane oxygenation initiation timing on tricuspid valve surgery outcomes. JTCVS Open. 2023; 14: 171–81. DOI: https://doi.org/10.1016/j.xjon.2023.02.012
36. Oliveros E., Collado F.M., Poulin M.F., Seder C.W., March R., Kavinsky C.J. Percutaneous right ventricular assist device using the TandemHeart ProtekDuo: real-world experience. J Invasive Cardiol. 2021; 33 (6): E 407–11. DOI: https://doi.org/10.25270/jic/20.00490
37. Seligman H., Vora A.N., Haroian N.Q., Puri R., Heng E.L., et al. The current landscape of transcatheter tricuspid valve intervention. J Soc Cardiovasc Angiogr Interv. 2023; 2 (6 pt B): 101201. DOI: https://doi.org/10.1016/j.jscai.2023.101201
38. Kazumyan B.V., Babenko S.I., Titov D.A., Muratov R.M. Risk factors and causes of late return of tricuspid regurgitation after suture and implant annuloplasty. Grudnaya i serdechno-sosudistaya khirurgiya [Thoracic and Cardiovascular Surgery]. 2023; 4 (65): 391–401. DOI: https://doi.org/10.24022/0236-2791-2023-65-4-391-401 (in Russian)
39. Sorajja P., Whisenant B., Hamid N., et al. Transcatheter repair for patients with tricuspid regurgitation. N Engl J Med. 2023; 388 (20): 1833–42. DOI: https://doi.org/10.1056/NEJMoa2300525
40. Jones T.K., McElhinney D.B., Vincent J.A., et al. Long-term outcomes after melody transcatheter pulmonary valve replacement in the US investigational device exemption trial. Circ Cardiovasc Interv. 2022; 15 (1): e010852. DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.121.010852

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)